Chlortetracycline

Chlortetracycline

SCHEMBL3841

CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12.Cl

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Chlortetracycline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 10/20 0.71
KMT2A Q03164 10/20 0.71
TDP1 Q9NUW8 7/20 0.71
MAPT P10636 6/20 0.71
USP2 O75604 5/20 0.71
HSD17B10 Q99714 4/20 0.71
GAA P10253 3/20 0.71
ALDH1A1 P00352 3/20 0.71
HPGD P15428 2/20 0.71
POLB P06746 3/20 0.70
LMNA P02545 3/20 0.70
THRB P10828 2/20 0.70
PLA2G1B P04054 1/20 0.70
ATG4B Q9Y4P1 1/20 0.70
HIF1A Q16665 1/20 0.70
PDE4A P27815 1/20 0.70
PADI4 Q9UM07 1/20 0.70
KDM4E B2RXH2 6/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
CYP3A4 P08684 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Chlortetracycline SCHEMBL29362279 1.00 MEN1 (0.71) MEN1KMT2ATDP1MAPTUSP2
Chlortetracycline SCHEMBL3842 1.00 MEN1 (0.71) MEN1KMT2ATDP1MAPTUSP2
Chlortetracycline SCHEMBL13782533 0.99 MAPT (0.71) MEN1KMT2ATDP1MAPTUSP2
Chlortetracycline SCHEMBL5503038 0.99 MAPT (0.71) MEN1KMT2ATDP1MAPTUSP2
Chlortetracycline SCHEMBL13782583 0.99 MAPT (0.71) MEN1KMT2ATDP1MAPTUSP2
Chlortetracycline SCHEMBL16726392 0.99 MAPT (0.71) MEN1KMT2ATDP1MAPTUSP2
Chlortetracycline SCHEMBL10901448 0.99 MAPT (0.71) MEN1KMT2ATDP1MAPTUSP2
Chlortetracycline SCHEMBL3110 0.99 MAPT (0.71) MEN1KMT2ATDP1MAPTUSP2
Chlortetracycline SCHEMBL20952683 0.99 MAPT (0.71) MEN1KMT2ATDP1MAPTUSP2
Chlortetracycline SCHEMBL12356689 0.99 MAPT (0.71) MEN1KMT2ATDP1MAPTUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 11109 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122071006-A Urea modified Bi2O3/g-C3N4Heterojunction catalyst and preparation method and application thereof 武汉纺织大学 2026-05-22 CN claimed
US-20260139860-A1 PRODUCTS OF MANUFACTURE FOR THE TREATMENT, PREVENTION AND AMELIORATION OF MICROBIAL INFECTIONS CENTRE FOR DIGESTIVE DISEASES (AU) 2026-05-21 US claimed
CN-116083472-B Recombinant vector, recombinant strain, kit, application of recombinant vector and recombinant strain and method for producing aureomycin 金河生物科技股份有限公司 2026-05-19 CN claimed
CN-122032649-A MnO (MnO)2EDTA catalyst and its prepn and application 昆明理工大学 2026-05-15 CN claimed
CN-122004360-A Natural plant feed raw material capable of replacing aureomycin and preparation method thereof 山西朗新生物科技有限公司 2026-05-12 CN claimed
EP-4680248-A1 PRODUCTS OF MANUFACTURE AND THERAPEUTIC COMPOSITIONS FOR TREATING, AMELIORATING OR PREVENTING VIRAL INFECTIONS AND METHODS FOR MAKING AND USING THEM Topelia Aust Limited (ACN 652 771 670) (AU) 2026-01-21 EP claimed
US-20250269005-A1 METHODS FOR TREATING, AMELIORATING OR PREVENTING INFECTIONS USING DRUG AND VACCINATION COMBINATION TREATMENT TOPELIA AUST LIMITED (ACN 652 771 670) (AU) 2025-08-28 US claimed
CN-120136235-A Treatment method and device for degrading tetracycline antibiotics in wastewater based on solar energy 汕头大学 2025-06-13 CN claimed
CN-120142264-A Ratio fluorescent probe for detecting aureomycin in meat food and detection method 河北大学 2025-06-13 CN claimed
CN-115557975-B Cu-based mixed ligand photo-Fenton catalyst and preparation method and application thereof 辽宁大学 2025-06-13 CN claimed
EP-0259904-B1 ADVANCED ANTICANCER THERAPY AND CYTOTOXIC MEDICAMENTS FOR ITS IMPLEMENTATION IntraCel Corporation (BB) 1991-06-12 EP claimed
EP-0372130-A1 Coating medical devices with cationic antibiotics C.R. BARD, INC. (US) 1990-06-13 EP claimed
US-4736024-A Process for preparing salt of hyaluronic acid with a pharmaceutically active substance FIDIA, S.P.A. (IT) 1988-04-05 US claimed
EP-0259904-A1 Advanced anticancer therapy and cytotoxic medicaments for its implementation IntraCel Corporation (BB) 1988-03-16 EP claimed
EP-0201057-A2 Bone targeted inhibitors of carbonic anhydrase RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1986-11-12 EP claimed
EP-0197718-A2 New medicaments for topical use FIDIA S.p.A. (IT) 1986-10-15 EP claimed
US-4126680-A TETRACYCLINE ANTIBIOTIC COMPOSITIONS PFIZER INC. (US) 1978-11-21 US claimed
US-4122158-A FOR TREATMENT OF BURNS; BIODEGRADABLE HYDROPHOBIC POLYMER; SUSTAINED RELEASE ALZA CORPORATION (US) 1978-10-24 US claimed
US-4081527-A Chlortetracycline compositions PFIZER INC. (US) 1978-03-28 US claimed
US-3983209-A HYDROPHOBIC BIOERODIBLE POLYMER, MICROBIOCIDE OR PROTEOLYTIC ENZYME ALZA CORPORATION (US) 1976-09-28 US claimed